Mingfu Zhu
No más puestos en curso
Historial de carrera de Mingfu Zhu
Antiguos cargos conocidos de Mingfu Zhu.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
20n Bio
 20n Bio BiotechnologyHealth Technology 20n Bio is a venture-backed startup based in Malvern, PA. The company's focus is on generating protein drugs in silico with desired biophysical, functional, and pharmacological properties. The company was founded in 2021 by Mingfu Zhu and is dedicated to using artificial intelligence to design novel protein therapeutics to address unmet medical needs. | Fundador | - | - |
Panorama Medicine, Inc.
 Panorama Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Panorama Medicine, Inc. operates a drug discovery platform that integrates genomics, big data, and computing to find drugs that can treat diseases caused by errors during RNA processing. The company was founded by Yi Xing, Mingfu Zhu, and Douglas Black in 2018 and is headquartered in Philadelphia, PA. | Director/Miembro de la Junta | 01/01/2018 | - |
| Director Ejecutivo | 01/01/2018 | - | |
| Fundador | 01/01/2018 | - |
Estadísticas
Internacional
| Estados Unidos | 3 |
Operativa
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorial
| Commercial Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Panorama Medicine, Inc.
Panorama Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Panorama Medicine, Inc. operates a drug discovery platform that integrates genomics, big data, and computing to find drugs that can treat diseases caused by errors during RNA processing. The company was founded by Yi Xing, Mingfu Zhu, and Douglas Black in 2018 and is headquartered in Philadelphia, PA. | Commercial Services |
20n Bio
20n Bio BiotechnologyHealth Technology 20n Bio is a venture-backed startup based in Malvern, PA. The company's focus is on generating protein drugs in silico with desired biophysical, functional, and pharmacological properties. The company was founded in 2021 by Mingfu Zhu and is dedicated to using artificial intelligence to design novel protein therapeutics to address unmet medical needs. | Health Technology |
- Bolsa de valores
- Insiders
- Mingfu Zhu
- Experiencia
